$3.575M Similasan eye drop class action settlement

Similasan has agreed to pay $3.575 million to resolve claims that its homeopathic eye drops were deceptively labeled.

The Similasan eye drop settlement benefits consumers who purchased Similasan homeopathic eye drops or certain private-label homeopathic eye drops at CVS or Walgreens for personal use between Sept. 11, 2017, and Feb. 20, 2025.

The settlement applies to the following products:

• Similasan Dry Eye Relief
• Similasan Complete Eye Relief
• Similasan Allergy Eye Relief
• Similasan Kids Allergy Eye Relief
• Similasan Red Eye Relief
• Similasan Pink Eye Relief
• Similasan Kids Pink Eye Relief
• Similasan Aging Eye Relief
• Similasan Computer Eye Relief
• Similasan Stye Eye Relief
• Similasan Pink Eye Nighttime Gel
• Similasan Dry Eye Nighttime Gel
• CVS Pink Eye Drops
• Walgreens Stye Eye Drops
• Walgreens Pink Eye Drops
• Walgreens Allergy Eye Drops

The settlement resolves allegations made in the Similasan false advertising class action lawsuit that the eye drops are deceptively labeled and advertised as homeopathic, misleadingly marketed as “sterile”, and fail to disclose the risk of silver sulfate. The defendant denies these allegations.

Similasan is a homeopathic remedy company that sells various products, including eye drops, under its own brand and private label lines at CVS and Walgreens.

Similasan has denied wrongdoing, but agreed to a $3.575 million class action settlement to resolve these allegations.

Under the terms of the Similasan eye drop settlement, qualifying settlement class members can receive the following settlement benefits:

Claimants without valid proof of purchase: Claimants without valid proof of purchase shall be eligible to receive $2.50 for each covered product purchased during the class period, subject to a maximum cash award of $10.00 per claim (i.e., each household can claim a cash award for a maximum of 4 covered products). Claims are limited to one per Household.

Claimants with valid proof of purchase: Claimants with valid proof of purchase for each purchase of a covered product shall be eligible to receive $2.50 for each covered product purchased during the class period, with no cap or limitation. Claims are limited to one per Household.

Claims are subject to pro rata increase or reduction per the terms of the settlement agreement.

The deadline to exclude yourself from the settlement or object to the settlement is May 27, 2025.

The final approval hearing for the Similasan class action settlement is scheduled for July 17, 2025.In order to receive settlement benefits, class members must submit a valid claim form by Oct. 15, 2025.

Who’s Eligible

Consumers who purchased certain Similasan, CVS or Walgreens products between Sept. 11, 2017, and Feb. 20, 2025. The settlement covers Similasan Dry Eye Relief, Similasan Complete Eye Relief, Similasan Allergy Eye Relief, Similasan Kids Allergy Eye Relief, Similasan Red Eye Relief, Similasan Pink Eye Relief, Similasan Kids Pink Eye Relief, Similasan Aging Eye Relief, Similasan Computer Eye Relief, Similasan Stye Eye Relief, Similasan Pink Eye Nighttime Gel, Similasan Dry Eye Nighttime Gel, CVS Pink Eye Drops, Walgreens Stye Eye Drops, Walgreens Pink Eye Drops and Walgreens Allergy Eye Drops.

Potential Award

Varies

Proof of Purchase

Store receipts, packaging or any other contemporaneous record of purchase

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

10/15/2025

Case Name

Plowden, et al. v. Similasan Corp., Case No. 1:23-cv-02511-DDD-STV, in the U.S. District Court for the District of Colorado

Final Hearing

07/17/2025

Settlement Website

HomeopathicEyeDropSettlement.com

Claims Administrator

Homeopathic Eye Drop Settlement
1650 Arch Street, Suite 2210
Philadelphia, PA19103
855-596-4080

Class Counsel

Melissa S. Weiner
PEARSON WARSHAW LLP

Rachel Soffin
Nick Suciu
MILBERG COLEMAN BRYSON PHILLIPS GROSSMAN PLLC

Jonas Jacobson
DOVEL & LUNER LLP
William H. Anderson
HANDLEY FARAH & ANDERSON PLLC

Defense Counsel

John C. Dougherty
Arameh O’Boyle
Katherine Galle
DENTONS US LLP

Greg Hearing
Melissa Jones
GORDON REES